logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Colorectal liver metastasis: bevacizumab vs cetuximab in head-to-head trial

Phase 2 randomized trial of patients receiving front-line mFOLFOX6.